HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

PRESS RELEASES

Lupin FY2020 Results

May 28, 2020

Lupin Receives Approval for Trientine Hydrochloride Capsules USP

May 22, 2020

Lupin Launches Authorized Generic Version of Apriso®

May 19, 2020

4QFY20 and FY20 Earnings Conference call on 29 May 2020

May 15, 2020

Lupin Extends ‘Jan Kovid’ Helpline for Bhopal and Indore Citizens

May 15, 2020

Lupin’s Vizag API Facility Receives EIR from U.S. FDA

May 14, 2020

Lupin’s Pithampur Facilities Complete Successful UK MHRA Inspection

May 08, 2020

Lupin Launches 'Jan Kovid' Helpline for Mumbai Citizens

May 06, 2020

Notice of Q4 FY2020 Board Meeting

May 05, 2020

Lupin Announces Positive Topline Results from its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis

May 04, 2020

Lupin’s Pithampur Unit-1 facility receives EIR from U.S. FDA

April 30, 2020

Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL

April 29, 2020

Lupin’s Mandideep Unit II Facility Receives EIR from U.S. FDA

April 15, 2020

Lupin’s Nagpur Facility Receives EIR from U.S. FDA

April 13, 2020

Lupin Contributes INR 21 crores Towards COVID-19 Relief Efforts

April 11, 2020

Lupin launches Mycophenolic Acid Delayed-Release Tablets USP

April 06, 2020

Lupin’s Aurangabad Facility Receives EIR from U.S. FDA

April 03, 2020

Lupin’s Inhalation Research Center, Florida receives EIR from U.S. FDA

March 30, 2020

Lupin and Mylan announce Positive European Medicines Agency opinion recommending Approval of Nepexto®, Biosimilar Etanercept

March 27, 2020

Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs

March 26, 2020

Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

March 20, 2020

Lupin Receives International Sustainability Rating System (ISRS) Certification, 8th Edition

March 12, 2020

Lupin wins India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference

March 09, 2020

Lupin Launches Authorized Generic version of Vimovo®

March 05, 2020

Lupin launches Ethacrynic Acid Tablets USP

February 25, 2020

LupinLife Collaborates With Payal Singhal and Mithali Raj at Lakmé Fashion Week 2020

February 21, 2020

U.S. FDA completes inspection of Lupin’s Aurangabad facility with Zero observation

February 18, 2020

Lupin launches Moxifloxacin Ophthalmic Solution USP 0.5%

February 14, 2020

Lupin Q3 FY2020 Results

February 06, 2020

Lupin receives approval for Leflunomide Tablets USP

February 05, 2020

Lupin’s Pithampur facilities complete successful MHRA inspection

January 27, 2020

Notice of 3QFY20 Earnings call

January 24, 2020

Notice of Q3 FY2020 Board Meeting

January 23, 2020

Lupin Foundation Wins IDMA Corporate Citizen Award 2019

January 21, 2020

Lupin and European Association of Urology Successfully Conclude Masterclass "Best of EAU19"

January 20, 2020

Lupin’s Ankleshwar Facility Wins Par Excellence Award at 33rd National Convention on Quality Concept

January 13, 2020

Lupin Appoints J. Alan Butcher as Chief Corporate Development Officer

January 10, 2020

Lupin’s Ankleshwar Facility Wins Gold Award from American Society for Quality

January 03, 2020